AMGLO DU
← Bio-Longevity & Human Optimization — Pioneer Ledger
H4-PIO-01Frontier Protocol

The Longevity Biomarker Discovery & Patent

Replaces: Post-Doctoral Gerontology and Cellular Aging Research

Core capability

Identifying, isolating, and patenting a specific biological mechanism that definitively slows or reverses cellular aging.

What this replaces

Post-Doctoral Gerontology and Cellular Aging Research.

Verification threshold

Peer-reviewed verification of the anti-aging mechanism, resulting in a secured patent and a commercialization pathway funded by AMGLO or a biotech VC.

The Progression Plan

Module 1: The Progression Plan

  • Phase 1 — Data Genesis48 min
  • Phase 2 — Kinetic Friction - The In-Vitro Proof56 min
  • Phase 3 — Synthesis - The Patent43 min
Credits
3
Estimated hours
43h
Lessons
3
Modules
1

Instructor

Henrik Lindqvist

Professor · Cyber-Physical Systems & Mechatronics